Please Continue to Support Desmoid Research
DTRF Co-Founder, Marlene Portnoy, and DTRF Scientific Director Dr. Mrinal Grounder candidly discuss the joint impact of DTRF's patient advocacy and Dr. Grounder's research that led to the breakthrough clinical trial of sorafenib.
We are pleased to share the publication of the first-of-its-kind global consensus paper on desmoid tumour treatment in the European Journal on Medicine.
Find a Physician
If you’ve been diagnosed with a desmoid tumour, you need experienced physicians helping you through the process.
Help Us Do More
Host your own event, create a fundraising campaign or encourage company donations. We’ve got the resources to help you out.
Desmoids Don’t Stop for COVID-19
While COVID-19 has impacted our daily lives, it does not stop desmoid tumours from growing. The mission of Desmoid Canada remains the same: raise funds for Desmoid Tumour Research. Desmoid Tumours are extremely rare, affecting 2 in 1 million. This year’s event cancellation leaves us uncertain of our ability to support vital research so if you can, please do consider a donation.
THANK YOU for supporting our DESMOID PATIENTS across Canada. If you have any questions, please email us at email@example.com.
Take good care everyone and stay healthy!
Subscribe to Our Mailing List
Subscribe to receive inspiration, ideas, and news in your inbox.
4th Annual Fundraising Event
Thursday, April 29th, 2021